| pubmed-article:15569871 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15569871 | lifeskim:mentions | umls-concept:C0007784 | lld:lifeskim |
| pubmed-article:15569871 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:15569871 | lifeskim:mentions | umls-concept:C0534191 | lld:lifeskim |
| pubmed-article:15569871 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:15569871 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15569871 | pubmed:dateCreated | 2004-12-24 | lld:pubmed |
| pubmed-article:15569871 | pubmed:abstractText | Hematoma growth occurs in 38% of intracerebral hemorrhage (ICH) patients scanned by computed tomography (CT) within 3 hours of onset. Activated recombinant factor VII (rFVIIa) promotes hemostasis at sites of vascular injury and may minimize hematoma growth after ICH. | lld:pubmed |
| pubmed-article:15569871 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15569871 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15569871 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15569871 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15569871 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15569871 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15569871 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15569871 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:15569871 | pubmed:issn | 1524-4628 | lld:pubmed |
| pubmed-article:15569871 | pubmed:author | pubmed-author:MayerStephan... | lld:pubmed |
| pubmed-article:15569871 | pubmed:author | pubmed-author:DiringerMicha... | lld:pubmed |
| pubmed-article:15569871 | pubmed:author | pubmed-author:SteinerThorst... | lld:pubmed |
| pubmed-article:15569871 | pubmed:author | pubmed-author:BroderickJose... | lld:pubmed |
| pubmed-article:15569871 | pubmed:author | pubmed-author:SkolnickBrett... | lld:pubmed |
| pubmed-article:15569871 | pubmed:author | pubmed-author:DavisStephenS | lld:pubmed |
| pubmed-article:15569871 | pubmed:author | pubmed-author:BrunNikolai... | lld:pubmed |
| pubmed-article:15569871 | pubmed:author | pubmed-author:Europe/Austra... | lld:pubmed |
| pubmed-article:15569871 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15569871 | pubmed:volume | 36 | lld:pubmed |
| pubmed-article:15569871 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15569871 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15569871 | pubmed:pagination | 74-9 | lld:pubmed |
| pubmed-article:15569871 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:meshHeading | pubmed-meshheading:15569871... | lld:pubmed |
| pubmed-article:15569871 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15569871 | pubmed:articleTitle | Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. | lld:pubmed |
| pubmed-article:15569871 | pubmed:affiliation | Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA. sam14@columbia.edu | lld:pubmed |
| pubmed-article:15569871 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15569871 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15569871 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15569871 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15569871 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15569871 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15569871 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15569871 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15569871 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15569871 | lld:pubmed |
